A nasty rash isn’t the only thing this shot may spare you from. A new study from the University of Southern California found ...
ATLANTA, GA, Oct. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today ...
Most COVID-19 vaccine hesitancy is rooted in concerns that can be addressed and effectively reduced over time, according to a new study following more than 1.1 million people in England between ...
Findings reveal a general decline in vaccine hesitancy during the 15 months following the COVID-19 vaccine roll-out in 2021-2022, with almost two-thirds of those initially hesitant going on to receive ...
In 2015, WHO defined vaccine hesitancy as a “delay in acceptance or refusal of vaccines despite availability of vaccination services”.1 More recently, it has been argued that the concept should be ...
A trio of new vaccines could provide a lifeline in the fight against cholera at a time when cases are soaring worldwide, ...